Olga Lyass
- Oncology top 5%
- Biomaterials top 2%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Biomedical Engineering top 10%
- Co-authors
- Alberto GabizónGerald J. BerryDinah TzemachMichal LotemAyala HubertTamar SafraFranco M. MuggiaSusan Groshen
- Topics
- Cancer Treatment and Pharmacology (9 papers)Chemotherapy-induced cardiotoxicity and mitigation (4 papers)Advanced Radiotherapy Techniques (3 papers)
- Cited by
- BiomaterialsRadiationOncology
- Journals
- Journal of Clinical OncologyCancerInternational Journal of Radiation Oncology*Biology*Physics
- Partner nations
- IsraelUnited StatesNetherlands
In The Last Decade
Olga Lyass
18 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 669
- Biomaterials 570
- Pulmonary and Respiratory Medicine 463
- Molecular Biology 427
- Biomedical Engineering 380
Countries citing papers authored by Olga Lyass
This map shows the geographic impact of Olga Lyass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Lyass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Lyass more than expected).
Fields of papers citing papers by Olga Lyass
This network shows the impact of papers produced by Olga Lyass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Lyass. The network helps show where Olga Lyass may publish in the future.
Co-authorship network of co-authors of Olga Lyass
This figure shows the co-authorship network connecting the top 25 collaborators of Olga Lyass. A scholar is included among the top collaborators of Olga Lyass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Lyass. Olga Lyass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 93 | |
| 2 | Prognostic factors for survival in metastatic breast cancer during first-line paclitaxel chemotherapy. | 15 |
| 3 | 29 | |
| 4 | Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignancies. | 39 |
| 5 | 156 | |
| 6 | 323 | |
| 7 | 72 | |
| 8 | Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2breakdown → | 505 |
| 9 | Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. | 40 |
| 10 | 209 | |
| 11 | 169 | |
| 12 | 10 | |
| 13 | 1 | |
| 14 | 65 | |
| 15 | 27 | |
| 16 | 93 | |
| 17 | Multiple parenchymal liver metastases as the first site of recurrent ovarian carcinoma: a case report and review of the literature. | 2 |
| 18 | 1 |
About Olga Lyass
Olga Lyass is a scholar working on Oncology, Radiation and Dermatology, having authored 18 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Advanced Radiotherapy Techniques (3 papers). The work is most often cited by research in Biomaterials (570 citations), Radiation (247 citations) and Oncology (669 citations). Olga Lyass has collaborated with scholars based in Israel, United States and Netherlands. Frequent co-authors include Alberto Gabizón, Gerald J. Berry, Dinah Tzemach, Michal Lotem, Ayala Hubert, Tamar Safra, Franco M. Muggia, Susan Groshen, Susan Jeffers and Denice Tsao‐Wei. Their work appears in journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.